15 stable patients diagnosed with schizophrenia take 100 mg of VLT-015 once a day, 200 mg of
VLT-015 once a day and 200 mg of VLT-015 on two consecutive days with an interval of 24 hours
between doses. PK parameters are measured, tolerability and safety of the product are
evaluated.